🟢 Niagen Bioscience is trading 6.5% up in pre-market after rebounding from August 6 close

Niagen Bioscience is trading at $3.24, up +6.47% in pre-market after closing at $3.04 on August 6, 2026.

• No major company-specific announcement was identified for August 7, 2026.
• The August 4 earnings release reported $29.8 million in second-quarter revenue, missing estimates, while EPS met expectations.
• Direct-to-consumer growth and maintained 10%–15% full-year sales-growth guidance provided longer-term support.